Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Nurse-Led Telehealth Frailty Management in Older Adults

1. November 2026 aktualisiert von: Kutahya Health Sciences University

The Effect of a Nurse-Led Telehealth-Supported Multicomponent Frailty Management Program on Frailty and Functional Status in Older Adults Living at Home: A Randomized Controlled Trial

Frailty can make older adults more vulnerable to loss of independence, falls, and hospitalization. This study evaluated whether a six-week nurse-led telephone education and counseling program could improve frailty and daily functioning in older adults living at home.

This single-center, two-arm, parallel-group randomized controlled trial included 122 adults aged 65 years or older who were frail or at risk of frailty and received home care services. Participants were randomly assigned to the intervention group or the usual care group, with 61 participants in each group.

Both groups continued to receive routine monthly home care. In addition, the intervention group received an initial face-to-face session followed by weekly telephone education and counseling sessions lasting approximately 20 to 25 minutes for six weeks. No additional intervention education or counseling was provided during weeks 7 to 18.

The primary outcome was frailty measured using the FRAIL Scale. Secondary outcomes included ability to perform instrumental activities of daily living, depressive symptoms, falls, emergency department visits, and hospitalizations. Frailty, daily functioning, and depressive symptoms were assessed at baseline, week 6, and week 18. Falls and health care use were recorded during the 18-week follow-up period. Outcome assessment and statistical analysis were conducted with treatment-group masking.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

The study was conducted through a hospital-based home care unit in Kütahya, Türkiye.

The intervention was delivered by a nurse with a master's degree. It began with an individual face-to-face assessment and education session lasting approximately 20 to 25 minutes, followed by one telephone education and counseling session per week for six weeks. Each telephone session lasted approximately 20 to 25 minutes.

The program addressed frailty awareness, safe physical activity and mobility, nutrition and fluid intake, fall prevention and home safety, medication and chronic disease self-management, sleep and fatigue management, social support, and healthy daily routines. Education and counseling were individualized to participants' needs and supported by an educational booklet and an individual action plan. A standardized checklist was used to document delivery of the intervention content and completion of the sessions. No additional intervention education or counseling was provided during weeks 7 to 18.

Participants in both groups continued routine monthly hospital-based home care services, including assessment of general health, blood pressure, pulse, body temperature, and pressure injuries. Adverse events were monitored weekly in both groups. Reports of deaths were obtained from relatives and reviewed alongside available health records.

Face-to-face outcome assessments were performed at baseline, week 6, and week 18 by a researcher who was unaware of group allocation. Frailty was assessed with the FRAIL Scale, functional status with the Lawton-Brody Instrumental Activities of Daily Living Scale, and depressive symptoms with the 15-item Geriatric Depression Scale. Falls, emergency department visits, and hospitalizations were recorded during follow-up.

Randomization and statistical analysis were performed by different researchers. The statistical analyst received groups coded as A and B and remained unaware of the intervention and control labels during the main analyses. Measurements obtained before withdrawal or death were retained; no measurements were imputed after death.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

122

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Kütahya
      • Simav, Kütahya, Türkei (türkiye), 43500
        • Simav Doc. Dr. Ismail Karakuyu State Hospital Home Care Unit

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

65 Jahre und älter (Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Aged 65 years or older
  • Living at home and not receiving institutional care
  • Frail or at risk of frailty
  • Having sufficient hearing and cognitive ability to communicate by telephone
  • Able to read, understand, and communicate in Turkish
  • Providing written informed consent

Exclusion Criteria:

  • Having advanced cognitive impairment such as dementia
  • Having hearing or speech problems that prevent communication
  • Being bedridden
  • Being in the terminal stage of illness
  • Participating in another intervention or education program at the same time
  • Having a serious physical or psychiatric condition that may prevent regular participation in the intervention

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Nurse-Led Telehealth-Supported Frailty Management Program

Participants received a six-week nurse-led telehealth-supported frailty management program in addition to routine monthly home care. A nurse with a master's degree delivered an initial face-to-face assessment and education session, followed by weekly telephone education and counseling sessions lasting approximately 20 to 25 minutes. An educational booklet and an individual action plan supported the intervention. Session completion and content delivery were documented using a standardized checklist. No additional intervention education or counseling was provided during weeks 7 to 18.

A six-week individualized education and counseling program delivered by a nurse with a master's degree. An initial face-to-face session and weekly telephone sessions each lasted approximately 20 to 25 minutes. Content addressed frailty awareness, safe physical activity and mobility, nutrition and fluid intake, fall prevention and home safety, medication and chronic disease self-management, sleep and fatigue management, social support, and healthy daily routines. An educational booklet and an individual action plan supported delivery. A standardized checklist documented session completion and content delivery. No additional intervention education or counseling was provided during weeks 7 to 18.

Kein Eingriff: Usual Care

Participants continued routine monthly hospital-based home care, including assessment of general health, blood pressure, pulse, body temperature, and pressure injuries. They did not receive the structured frailty education and telephone counseling program. Outcome assessments and weekly adverse event monitoring followed the same schedule as in the intervention group.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Frailty Level Assessed by the FRAIL Scale
Zeitfenster: Baseline, 6 weeks, and 18 weeks

Frailty level will be assessed using the FRAIL Scale. The FRAIL Scale consists of five components: fatigue, resistance, ambulation, illnesses, and weight loss. Total scores range from 0 to 5. Higher scores indicate greater frailty. A score of 0 indicates robust status, scores of 1 to 2 indicate pre-frailty, and scores of 3 to 5 indicate frailty.

Baseline, 6 weeks, and 18 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Functional Status Assessed by the Lawton-Brody Instrumental Activities of Daily Living Scale
Zeitfenster: Baseline, 6 weeks, and 18 weeks

Functional status will be assessed using the Lawton-Brody Instrumental Activities of Daily Living Scale. Total scores range from 0 to 8. Higher scores indicate greater independence in instrumental activities of daily living.

Baseline, 6 weeks, and 18 weeks
Depressive Symptoms Assessed by the 15-Item Geriatric Depression Scale
Zeitfenster: Baseline, 6 weeks, and 18 weeks

Depressive symptoms will be assessed using the 15-item Geriatric Depression Scale. Total scores range from 0 to 15. Higher scores indicate more severe depressive symptoms. Scores of 0 to 4 indicate no depression, 5 to 8 indicate mild depression, 9 to 11 indicate moderate depression, and 12 to 15 indicate severe depression.

Baseline, 6 weeks, and 18 weeks
Number of Falls During the Study Period
Zeitfenster: From baseline to 18 weeks

The number of falls experienced by participants during the study period will be recorded using a fall and health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates more falls.

From baseline to 18 weeks
Number of Emergency Department Visits During the Study Period
Zeitfenster: From baseline to 18 weeks

The number of emergency department visits during the study period will be recorded using a health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates greater emergency health care utilization.

From baseline to 18 weeks
Number of Hospitalizations During the Study Period
Zeitfenster: From baseline to 18 weeks

The number of hospitalizations during the study period will be recorded using a health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates greater hospital utilization.

From baseline to 18 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

5. Juni 2026

Primärer Abschluss (Tatsächlich)

22. Oktober 2026

Studienabschluss (Tatsächlich)

22. Oktober 2026

Studienanmeldedaten

Zuerst eingereicht

4. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

4. Juni 2026

Zuerst gepostet (Tatsächlich)

8. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

4. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

1. November 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • KSBU-FRAIL-RCT-2026-01

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

De-identified individual participant data underlying the findings reported in the main publication, together with the associated data dictionary, will be made available to researchers upon reasonable request to the corresponding author for 5 years following publication of the main study article. The data will not be posted publicly to protect participant privacy. Access will be subject to applicable ethical and participant-consent requirements.

IPD-Sharing-Zeitrahmen

Data will be available from publication of the main study article and will remain available for 5 years.

IPD-Sharing-Zugriffskriterien

Researchers may request access by emailing Serkan Budak at serkan.budak@ksbu.edu.tr and describing the research question, intended analyses, and data required. The corresponding author will review requests for scientific relevance, participant confidentiality, and compliance with applicable ethical and consent requirements. Approved requests will receive de-identified data and the associated data dictionary.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • SAFT
  • ANALYTIC_CODE

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .